Inflammatory microenvironment regulates colorectal cancer progression
4 May 2016
Inflammatory microenvironment regulates colorectal cancer progression
Editor's Choice for April 2016
Pembrolizumab yielded durable responses in patients with advanced Merkel cell carcinoma
Combination therapy before surgery improves outcomes for patients with HER2 positive breast cancer
Elucidation and pharmacological targeting of tumour checkpoint dependencies
AML17 Trial results: maximum dosage of daunorubicin in AML
AML during pregancy
The future of haematopathology
BSH 2016: Expert discussion on front line care in CLL
SPF30 sunscreens delay melanoma incidence in preclinical model
WIN 2016: Preview of themes
WIN 2016: Preview of Speakers